$KRMD

REPRO MED SYSTEMS INC

CIK:0000704440|SEC Filings

STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
NET REVENUES	$ 12,045,420	$ 10,194,800	$ 23,810,044	$ 19,829,875
Cost of goods sold	4,199,212	3,719,031	8,732,447	7,307,771
Gross Profit	7,846,208	6,475,769	15,077,597	12,522,104
OPERATING EXPENSES
Selling, general and administrative	5,939,986	5,384,148	12,522,165	11,343,522
Research and development	1,069,200	1,194,789	2,385,804	2,309,398
Depreciation and amortization	210,031	209,487	407,561	426,844
Total Operating Expenses	7,219,217	6,788,424	15,315,530	14,079,764
Net Operating Income /(Loss)	626,991	(312,655)	(237,933)	(1,557,660)
Non-Operating Income/(Expense)
Gain/(Loss) on currency exchange	(22,343)	44,193	(45,493)	49,782
Loss on disposal of fixed assets, net	(406,269)		(406,269)
Interest income, net	59,870	78,951	140,866	152,130
TOTAL OTHER (EXPENSE)/INCOME	(368,742)	123,144	(310,896)	201,912
INCOME / (LOSS) BEFORE INCOME TAXES	258,249	(189,511)	(548,829)	(1,355,748)
Income Tax Expense	(5,800)	(17,356)	(5,800)	(17,356)
NET INCOME/(LOSS)	$ 252,449	$ (206,867)	$ (554,629)	$ (1,373,104)
NET INCOME / (LOSS) PER SHARE
Basic	$ 0.01	$ (0.00)	$ (0.01)	$ (0.03)
Diluted	$ 0.01	$ (0.00)	$ (0.01)	$ (0.03)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING
Basic	46,083,893	46,193,709	46,223,623	46,088,353
Diluted	49,509,437	46,193,709	46,223,623	46,088,353

STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	Jun. 30, 2026	Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (554,629)	$ (1,373,104)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense and warrant expense	1,139,284	1,113,334
Depreciation and amortization	407,561	426,844
Loss on disposal of fixed assets	406,269
Non-cash leasing charges	(2,931)
Changes in operating assets and liabilities:
Decrease/(Increase) in accounts receivable	944,529	805,133
Decrease/(Increase) in other receivables	(507,257)	47,979
Decrease/(Increase) in inventory	(832,996)	(1,144,175)
Decrease/(Increase) in prepaid expenses and other assets	285,887	317,897
Increase/(Decrease) in accounts payable	645,116	(555,430)
Increase/(Decrease) in accrued payroll and related taxes	275,860	(122,459)
Increase/(Decrease) in other liabilities	(16,654)	74,833
Increase/(Decrease) in accrued expenses	(1,959,263)	(288,659)
NET CASH FLOWS FROM OPERATING ACTIVITIES	230,776	(697,807)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment	(154,070)	(472,252)
Purchases of intangible assets	(461,035)	(3,400)
Capitalized software development costs	(52,147)
NET CASH FLOWS FROM INVESTING ACTIVITIES	(667,252)	(475,652)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments on insurance finance indebtedness		(271,152)
Payments for taxes related to net share settlement of equity awards	(81,059)	(27,536)
Payments on finance lease liability, net of asset	(66,973)	(54,084)
NET CASH FLOWS FROM FINANCING ACTIVITIES	(148,032)	(352,772)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(584,508)	(1,526,231)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	8,872,212	9,580,947
CASH AND CASH EQUIVALENTS, END OF PERIOD	8,287,704	8,054,716
Cash paid during the years for:
Interest	4,732	7,563
Income Taxes	$ 5,800	$ 17,356

BALANCE SHEETS - USD ($)	Jun. 30, 2026	Dec. 31, 2025
CURRENT ASSETS
Cash and cash equivalents	$ 8,287,704	$ 8,872,212
Accounts receivable, net	5,027,723	5,972,252
Inventory, net	4,511,126	3,678,131
Other receivables	1,064,909	557,653
Prepaid expenses and other current assets	622,655	908,542
TOTAL CURRENT ASSETS	19,514,117	19,988,790
Property and equipment, net	3,929,718	4,471,386
Intangible assets, net of accumulated amortization of $562,655 and $527,949 as of June 30, 2026 and December 31, 2025, respectively	1,663,318	684,841
Operating lease right-of-use assets	2,755,890	2,956,192
Other assets	98,970	98,970
TOTAL ASSETS	27,962,013	28,200,179
CURRENT LIABILITIES
Accounts payable	2,912,589	2,267,473
Accrued expenses	2,869,568	4,828,830
Other liabilities	11,068	27,722
Accrued payroll and related taxes	807,832	531,972
Financing lease liability	148,592	124,913
Operating lease liability	430,173	413,448
TOTAL CURRENT LIABILITIES	7,179,822	8,194,358
Financing lease liability, net of current portion	71,409	78,675
Operating lease liability, net of current portion	2,659,265	2,879,224
TOTAL LIABILITIES	9,910,496	11,152,257
STOCKHOLDERS’ EQUITY
Common stock, $0.01 par value, 75,000,000 shares authorized, 50,172,404 and 49,790,934 shares issued 46,148,690 and 46,370,432 shares outstanding as of June 30, 2026, and December 31, 2025, respectively	501,724	497,909
Additional paid-in capital	56,527,047	52,449,339
Treasury stock, 4,018,526 and 3,438,526 shares as of June 30, 2026 and December 31, 2025, respectively, at cost	(6,405,793)	(3,882,494)
Accumulated deficit	(32,571,461)	(32,016,832)
TOTAL STOCKHOLDERS’ EQUITY	18,051,517	17,047,922
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 27,962,013	$ 28,200,179